Trial to Assess the Safety and Clinical Performance of Contino® in Preventing Urinary Incontinence

Inclusion Criteria: 1. Male 18 years of age or older 2. Evidence of sphincteric incompetence as assessed by the Investigator 3. ECOG 0 or 1 performance status 4. Evidence of moderate to severe urinary incontinence as assessed by the Investigator, typically 2 or more protective garments or pads per day Exclusion Criteria: 1. Inability to consistently insert the Contino® into his own urethra and remove it 2. Less than 2 months post radical prostatectomy for localized prostate cancer 3. History of significant incontinence that is other than stress incontinence 4. Evidence of neurogenic bladder dysfunction resulting in uncontrolled contractions 5. Untreated urethral stricture disease 6. Use of anticoagulant or antiplatelet medications excluding low-dose ASA (in the opinion of the Investigator) 7. Any cardiac condition that requires the use of pre-procedure antibiotic prophylaxis such as a mechanical valve (in the opinion of the Investigator) 8. Body Mass Index (BMI) greater than 32 kg/m2 (in the opinion of the Investigator provided the subject is able to insert \& remove the device) 9. Known immune deficiency either due to disease or medications (in the opinion of the Investigator) 10. Uncontrolled diabetes (in the opinion of the Investigator) 11. An UTI (in the opinion of the Investigator)